Literature DB >> 3929873

Effect of isosorbide dinitrate, verapamil, and labetalol on portal pressure in cirrhosis.

J G Freeman, J R Barton, C O Record.   

Abstract

The effects on portal pressure of the vasodilatory drugs isosorbide dinitrate and verapamil and of an alpha and beta blocking agent, labetalol, were assessed in 21 patients with cirrhosis and portal hypertension. The wedged hepatic venous pressure gradient (wedged minus free hepatic venous pressures) was used as an index of portal pressure and was not significantly changed by treatment with labetalol (n = 5) but was significantly decreased by verapamil (n = 6; p less than 0.05) and isosorbide dinitrate (n = 10; p less than 0.01). Long term administration of isosorbide dinitrate also had a significant effect (p less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929873      PMCID: PMC1418205          DOI: 10.1136/bmj.291.6495.561

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  4 in total

1.  A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report.

Authors:  D Lebrec; T Poynard; J Bernuau; E Bercoff; O Nouel; J P Capron; R Poupon; M Bouvry; B Rueff; J P Benhamou
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

2.  Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.

Authors:  R Hallemans; R Naeije; P Mols; C Mélot; P Reding
Journal:  Crit Care Med       Date:  1983-07       Impact factor: 7.598

3.  Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis.

Authors:  A K Burroughs; W J Jenkins; S Sherlock; A Dunk; R P Walt; T O Osuafor; S Mackie; R Dick
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

4.  Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.

Authors:  R J Groszmann; D Kravetz; J Bosch; M Glickman; J Bruix; J Bredfeldt; H O Conn; J Rodes; E H Storer
Journal:  Hepatology       Date:  1982 Nov-Dec       Impact factor: 17.425

  4 in total
  12 in total

1.  Effects of calcium antagonists on hepatic and systemic hemodynamics in awake portal hypertensive rats.

Authors:  M Nagasawa; T Kawasaki; T Yoshimi
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

2.  Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: role of prostaglandin.

Authors:  Chii-Shyan Lay; C-M-Y May; Fa-Yauh Lee; Yang-Te Tsai; Shou-Dong Lee; Shu Chien; Shlomoh Sinchon
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

3.  Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.

Authors:  A L Jones; I H Bangash; J Walker; K J Simpson; N D Finlayson; P C Hayes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 4.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

5.  Lack of effect of verapamil and isosorbide dinitrate on the hepatic clearance of indocyanine green in cirrhosis.

Authors:  C Merkel; M Bolognesi; P Angeli; G F Finucci; P Amodio; S Bellon; A Gatta
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

Review 6.  Nitrate tolerance. A review of the evidence.

Authors:  J T Flaherty
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

7.  Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver.

Authors:  J Reichen; M Le
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

8.  The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.

Authors:  C Merkel; A Gatta; M Bolognesi; R Padrini; G F Finucci; P Angeli; A Ruol
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

9.  Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis.

Authors:  T Sauerbruch; G Kleber; A Gerbes; G Paumgartner
Journal:  Klin Wochenschr       Date:  1986-12-15

10.  Effect and mechanism of action of isosorbide-5-mononitrate.

Authors:  P C Hayes; D Westaby; R Williams
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.